Ray Dalio's XYL Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 39,593 shares of Xylem Inc. (XYL) worth $5.39 M, representing 0.02% of the portfolio. First purchased in 2016-Q2, this long-term strategic position has been held for 28 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in XYL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 76,902 shares. Largest reduction occurred in Q3 2021, reducing 48,720 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Xylem (XYL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Xylem (XYL) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +32,635 | Add 469.03% | 39,593 | $136.18 |
| Q3 2025 | +6,958 | New Buy | 6,958 | $147.50 |
| Q2 2025 | -1,968 | Sold Out | 0 | $0.00 |
| Q1 2025 | -514 | Reduce 20.71% | 1,968 | $119.46 |
| Q4 2024 | +927 | Add 59.61% | 2,482 | $116.02 |
| Q3 2024 | -111 | Reduce 6.66% | 1,555 | $135.03 |
| Q2 2024 | -5,685 | Reduce 77.34% | 1,666 | $135.63 |
| Q1 2024 | -14,705 | Reduce 66.67% | 7,351 | $129.24 |
| Q4 2023 | -834 | Reduce 3.64% | 22,056 | $114.36 |
| Q3 2023 | -1,430 | Reduce 5.88% | 22,890 | $91.03 |
| Q2 2023 | -5,139 | Reduce 17.44% | 24,320 | $112.62 |
| Q1 2023 | -22,425 | Reduce 43.22% | 29,459 | $104.70 |
| Q4 2022 | -1,272 | Reduce 2.39% | 51,884 | $110.57 |
| Q3 2022 | -15,385 | Reduce 22.45% | 53,156 | $87.37 |
| Q2 2022 | -43,526 | Reduce 38.84% | 68,541 | $78.19 |
| Q1 2022 | +76,902 | Add 218.69% | 112,067 | $85.26 |
| Q4 2021 | +35,165 | New Buy | 35,165 | $119.92 |
| Q3 2021 | -48,720 | Sold Out | 0 | $0.00 |
| Q2 2021 | +48,720 | New Buy | 48,720 | $119.95 |
| Q1 2021 | -18,152 | Sold Out | 0 | $0.00 |
| Q4 2020 | +4,837 | Add 36.33% | 18,152 | $101.81 |
| Q3 2020 | +13,315 | New Buy | 13,315 | $84.12 |
| Q1 2020 | -7,680 | Sold Out | 0 | $0.00 |
| Q4 2019 | +7,680 | New Buy | 7,680 | $78.78 |
| Q3 2018 | -21,337 | Sold Out | 0 | $0.00 |
| Q2 2018 | +21,337 | New Buy | 21,337 | $67.39 |
| Q3 2016 | -13,100 | Sold Out | 0 | $0.00 |
| Q2 2016 | +13,100 | New Buy | 13,100 | $44.66 |
Ray Dalio's Xylem Investment FAQs
Ray Dalio first purchased Xylem Inc. (XYL) in Q2 2016, acquiring 13,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Xylem Inc. (XYL) for 28 quarters since Q2 2016.
Ray Dalio's largest addition to Xylem Inc. (XYL) was in Q1 2022, adding 112,067 shares worth $9.56 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 39,593 shares of Xylem Inc. (XYL), valued at approximately $5.39 M.
As of the Q4 2025 filing, Xylem Inc. (XYL) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Xylem Inc. (XYL) was 112,067 shares, as reported at the end of Q1 2022.